Alkem Laboratories Ltd

ALKEM
Health CarePharmaceuticals
MidcapWith a market cap of ₹41,239 cr, stock is ranked 122
Low RiskStock is 1.53x as volatile as Nifty
3,457.558.45 (+0.24%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
MidcapWith a market cap of ₹41,239 cr, stock is ranked 122
Low RiskStock is 1.53x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
26.02
PB RatioPB Ratio
5.46
Dividend YieldDiv. Yield
0.87%
Sector PESector PE
38.05
Sector PBSector PB
5.10
Sector Div YldSctr Div Yld
0.68%

Forecast & RatingsDetailed Forecast 

65%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Alkem Laboratories Limited is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.

Brands

Alkem Labs

Pharmaceutical company

Investor PresentationView older 

Nov 12, 2021

PDF
View Older Presentations

Brands

Alkem Labs

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020216.527.448.459.100.630.761.131.59
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 1.32%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Disclosure under SEBI (PIT) Reg 2015 
Announced OnDec 2, 2021

Alkem Laboratories Limited has informed the Exchange that Disclosures under Regulations 4(1) of SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download

Alkem Laboratories Limited has informed the Exchange that Disclosures under Regulations 4(1) of SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download

Related Party Transactions 
Announced OnNov 30, 2021

Alkem Laboratories Limited has informed the Exchange about related Party Transactions | Download

Alkem Laboratories Limited has informed the Exchange about related Party Transactions | Download

Cash Dividend 
Ex. DateAug 9, 2021

Final • Div/Share: ₹ 5

See all events